NOT KNOWN FACTUAL STATEMENTS ABOUT SR9009

 one prior program of chemotherapy for Sophisticated breast cancer and over the whole trial, prior exposure to any FGFR inhibitor, key surgical procedure or radiotherapy in just 4 weeks before 1st dose of review cure and taking potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the next cardiac requirements precluded clients moving into: N